Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $497.27 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $116.99 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $108.43 | 4 | $0 (2024) |
| QOL Medical, LLC | $63.70 | 3 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $62.56 | 3 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $32.94 | 2 | $0 (2019) |
| Celltrion USA Inc. | $27.41 | 1 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $24.53 | 1 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $17.51 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $16.58 | 1 | $0 (2023) |
| Braintree Laboratories, Inc. | $15.34 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.08 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($71.13) |
| 2023 | $87.63 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($30.39) |
| 2022 | $55.46 | 2 | Janssen Biotech, Inc. ($55.46) |
| 2020 | $26.12 | 1 | Intercept Pharmaceuticals, Inc. ($26.12) |
| 2019 | $69.21 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($19.80) |
| 2018 | $39.89 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($15.47) |
| 2017 | $19.88 | 1 | Intercept Pharmaceuticals, Inc. ($19.88) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.11 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/01/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.39 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/03/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $20.20 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/30/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Immunology | ||||||
| 02/22/2023 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology | ||||||
| 08/12/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: Immunology | ||||||
| 02/21/2020 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 10/25/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/30/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 06/07/2019 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug), MOTOFEN | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: GI COLON PREP | ||||||
| 02/12/2019 | Mallinckrodt Enterprises LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: ACUTE CARE | ||||||
| 06/26/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | MOVIPREP (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/12/2018 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Lower GI | ||||||
| 08/24/2017 | Intercept Pharmaceuticals, Inc. | OCA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 164 | 164 | $216,690 | $18,582 |
| 2022 | 6 | 169 | 169 | $262,485 | $19,582 |
| 2021 | 6 | 246 | 248 | $399,476 | $29,110 |
| 2020 | 5 | 143 | 144 | $248,502 | $18,376 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 58 | 58 | $72,930 | $6,417 | 8.8% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 28 | 28 | $40,754 | $3,490 | 8.6% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 27 | 27 | $33,306 | $2,874 | 8.6% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 20 | 20 | $31,870 | $2,700 | 8.5% |
| 00520 | Anesthesia for other closed procedure on chest | Facility | 2023 | 13 | 13 | $27,354 | $2,424 | 8.9% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 18 | 18 | $10,476 | $676.98 | 6.5% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 61 | 61 | $91,881 | $7,827 | 8.5% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 37 | 37 | $63,495 | $4,437 | 7.0% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 30 | 30 | $58,515 | $4,231 | 7.2% |
| 00142 | Anesthesia for lens surgery | Facility | 2022 | 14 | 14 | $22,410 | $1,306 | 5.8% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 12 | 12 | $16,434 | $1,214 | 7.4% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 15 | 15 | $9,750 | $567.13 | 5.8% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 83 | 83 | $127,755 | $10,471 | 8.2% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 49 | 49 | $96,910 | $6,783 | 7.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 52 | 52 | $90,541 | $6,185 | 6.8% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 24 | 24 | $36,727 | $2,628 | 7.2% |
| 00142 | Anesthesia for lens surgery | Facility | 2021 | 21 | 23 | $37,101 | $2,572 | 6.9% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 17 | 17 | $10,442 | $470.90 | 4.5% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 67 | 67 | $106,074 | $8,438 | 8.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 28 | 28 | $48,555 | $3,401 | 7.0% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 19 | 19 | $39,591 | $2,778 | 7.0% |
| 00142 | Anesthesia for lens surgery | Facility | 2020 | 16 | 16 | $27,888 | $1,931 | 6.9% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Facility | 2020 | 13 | 14 | $26,394 | $1,828 | 6.9% |
About Dr. Jackie Phan, M.D
Dr. Jackie Phan, M.D is a Anesthesiology healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225277817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jackie Phan, M.D has received a total of $497.27 in payments from pharmaceutical and medical device companies, with $199.08 received in 2024. These payments were reported across 24 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($497.27).
As a Medicare-enrolled provider, Phan has provided services to 722 Medicare beneficiaries, totaling 725 services with total Medicare billing of $85,651. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Daly City, CA
- Active Since 02/05/2009
- Last Updated 05/03/2013
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225277817
Products in Payments
- ENTYVIO (Biological) $80.67
- STELARA (Biological) $55.46
- SUCRAID (Drug) $43.50
- OCALIVA (Drug) $42.68
- TREMFYA (Drug) $32.51
- VEGZELMA (Biological) $27.41
- VOQUEZNA (Drug) $24.53
- EOHILIA (Drug) $20.85
- REMICADE (Biological) $20.46
- Sucraid (Drug) $20.20
- OCA (Drug) $19.88
- XIFAXAN (Drug) $19.80
- OFIRMEV (Drug) $17.51
- BRIDION (Drug) $16.58
- Entyvio (Biological) $15.47
- SUPREP BOWEL PREP (Drug) $15.34
- MOVIPREP (Drug) $13.14
- Kcentra (Biological) $11.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Daly City
Jennifer Reodica, M.d, M.D
Anesthesiology — Payments: $1,251
Dr. Christopher Viale, Md, MD
Anesthesiology — Payments: $1,214
Adam Dziuba, Md, MD
Anesthesiology — Payments: $654.86
Michael Bigelow, Md, MD
Anesthesiology — Payments: $495.32
Joseph Lee, Md, MD
Anesthesiology — Payments: $432.51
Catherine Hamilton, Md, MD
Anesthesiology — Payments: $369.23